# Mp-3TMRI and 68Ga-PSMA PET/CT Guided Prostate Biopsy and Tumor Node Metastasis (TNM) Staging.

> **NCT03465579** · NA · TERMINATED · sponsor: **Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS** · enrollment: 261 (actual)

## Conditions studied

- 68Ga-PSMA PET/CT Guided Prostate Biopsy
- Mp-3TMRI Guided Prostate Biopsy
- Prostate Cancer
- TNM Staging
- Diagnosis

## Interventions

- **DIAGNOSTIC_TEST:** pelvic MRI
- **DIAGNOSTIC_TEST:** 68Ga-PSMA PET/CT

## Key facts

- **NCT ID:** NCT03465579
- **Lead sponsor:** Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-05-23
- **Primary completion:** 2024-09-03
- **Final completion:** 2024-09-03
- **Target enrollment:** 261 (ACTUAL)
- **Why stopped:** Patients in cohort 1 continued for prolonged periods given the difficulties encountered in the COVID period and to date in this setting evidence has already developed that reduces the the innovativeness of the project.
- **Last updated:** 2025-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03465579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03465579, "Mp-3TMRI and 68Ga-PSMA PET/CT Guided Prostate Biopsy and Tumor Node Metastasis (TNM) Staging.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03465579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*